Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2013
DOI: 10.1134/s1070363213120542
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceuticals for binary radiotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 17 publications
0
3
0
1
Order By: Relevance
“…Thereby existing drugs already approved for clinical use, such as MRI and X-ray contrast drugs, could be used for treating certain types of tumor with Binary Radiotherapy. Also, new non-toxic inert BRT-drugs with no physiological activity could be developed and approved for clinical use in Binary Radiotherapy (Kulakov et al, 2013). Gold and gadolinium nanoparticles probably can be used for that purpose.…”
Section: Groupmentioning
confidence: 99%
See 1 more Smart Citation
“…Thereby existing drugs already approved for clinical use, such as MRI and X-ray contrast drugs, could be used for treating certain types of tumor with Binary Radiotherapy. Also, new non-toxic inert BRT-drugs with no physiological activity could be developed and approved for clinical use in Binary Radiotherapy (Kulakov et al, 2013). Gold and gadolinium nanoparticles probably can be used for that purpose.…”
Section: Groupmentioning
confidence: 99%
“…Binary Radiotherapy is a developing method of radiotherapy which uses special pharmaceuticals (let us call them BRT-drugs) to form absorbed dose field of desirable shape (Kulakov et al, 2013). Formation of absorbed dose field is caused by preferential interaction of external radiation with specific element (absorbing element) contained in a BRT-drug (Sheino, 2006).…”
Section: Introductionmentioning
confidence: 99%
“…A. A. Lipengol'ts 1,2,3 , A. A. Cherepanov 1 Antitumor efficacy of the photon capture therapy (or contrast enhanced radiotherapy, CERT) in high extent depends on the properties of particular drug containing a high-Z chemical element with high capability of absorbing external x-rays.…”
Section: Comparative Antitumor Efficacy Of Bismuth and Gadolinium As mentioning
confidence: 99%
“…Ýòî óäàåòñÿ ðåàëèçîâàòü â áèíàðíûõ òåõíîëîãèÿõ, îäíîé èç êîòîðûõ ÿâëÿåòñÿ ôîòîí-çàõâàòíàÿ òåðàïèÿ (ÔÇÒ). Òåðàïåâòè÷åñêàÿ ýôôåêòèâíîñòü òåõíîëîãèè ÔÇÒ çàêëþ÷àåòñÿ â ñîçäàíèè òóìîðîöèäíîé äîçû â îáëó÷àåìîé ìèøåíè çà ñ÷åò ïðåèìóùåñòâåííîãî âçàèìîäåéñòâèÿ âíåøíåãî èîíèçèðóþùåãî èçëó÷åíèÿ ñ äîçîïîâûøàþùèì àãåíòîì (ÄÏÀ), ñîäåðaeàùåìñÿ â ñïåöèàëüíîì ïðåïàðàòå, ââîäèìîì èëè íàêàïëèâàþùåìñÿ â îïóõîëè [2,3]. Òàêîå ïðåèìóùåñòâåííîå ïîãëîùåíèå ïîçâîëÿåò îáåñïå÷èòü â îáëàñòè ëîêàëèçàöèè ÄÏÀ âåëè÷èíó ïîãëîùåííîé äîçû â 1,5 -3 ðàçà áîëüøå, ÷åì â îêðóaeàþùèõ çäîðîâûõ òêàíÿõ [4 -7].…”
unclassified